DODD 6025.21E(D)
MEDICAL RESEARCH FOR PREVENTION, MITIGATION, AND TREATMENT OF BLAST INJURIES
Organization:
DODD - DoD Directives Service
Year: 2006
Abstract: PURPOSE
This Directive:
Implements Reference (a) by establishing policy and assigning responsibilities governing coordination and management of medical research efforts and DoD programs related to prevention, mitigation, and treatment of blast injuries.
Designates the Secretary of the Army, in compliance with Reference (a) and consistent with Reference (b), as the DoD Executive Agent (DoD EA) for Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries according to Reference (b).
Establishes the Armed Services Biomedical Research Evaluation and Management (ASBREM) Committee. The ASBREM Committee serves to facilitate coordination and prevent unnecessary duplication of effort within DoD biomedical research and development and associated enabling research areas, to include serving as the forum for implementation of subsections (d) and (g) of Reference (a).
APPLICABILITY
This Directive applies to:
The Office of the Secretary of Defense, the Military Departments, the Chairman of the Joint Chiefs of Staff, the Combatant Commands, the Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD Field Activities, and all other organizational entities in the Department of Defense (hereafter collectively referred to as the “DoD Components”).
Medical and associated enabling research supported by any DoD Component for prevention, mitigation, and treatment of blast injuries.
This Directive:
Implements Reference (a) by establishing policy and assigning responsibilities governing coordination and management of medical research efforts and DoD programs related to prevention, mitigation, and treatment of blast injuries.
Designates the Secretary of the Army, in compliance with Reference (a) and consistent with Reference (b), as the DoD Executive Agent (DoD EA) for Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries according to Reference (b).
Establishes the Armed Services Biomedical Research Evaluation and Management (ASBREM) Committee. The ASBREM Committee serves to facilitate coordination and prevent unnecessary duplication of effort within DoD biomedical research and development and associated enabling research areas, to include serving as the forum for implementation of subsections (d) and (g) of Reference (a).
APPLICABILITY
This Directive applies to:
The Office of the Secretary of Defense, the Military Departments, the Chairman of the Joint Chiefs of Staff, the Combatant Commands, the Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD Field Activities, and all other organizational entities in the Department of Defense (hereafter collectively referred to as the “DoD Components”).
Medical and associated enabling research supported by any DoD Component for prevention, mitigation, and treatment of blast injuries.
Collections
:
-
Statistics
DODD 6025.21E(D)
Show full item record
| contributor author | DODD - DoD Directives Service | |
| date accessioned | 2017-09-04T15:47:14Z | |
| date available | 2017-09-04T15:47:14Z | |
| date copyright | 07/05/2006 | |
| date issued | 2006 | |
| identifier other | PXPIJBAAAAAAAAAA.pdf | |
| identifier uri | https://yse.yabesh.ir/std/handle/yse/50021 | |
| description abstract | PURPOSE This Directive: Implements Reference (a) by establishing policy and assigning responsibilities governing coordination and management of medical research efforts and DoD programs related to prevention, mitigation, and treatment of blast injuries. Designates the Secretary of the Army, in compliance with Reference (a) and consistent with Reference (b), as the DoD Executive Agent (DoD EA) for Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries according to Reference (b). Establishes the Armed Services Biomedical Research Evaluation and Management (ASBREM) Committee. The ASBREM Committee serves to facilitate coordination and prevent unnecessary duplication of effort within DoD biomedical research and development and associated enabling research areas, to include serving as the forum for implementation of subsections (d) and (g) of Reference (a). APPLICABILITY This Directive applies to: The Office of the Secretary of Defense, the Military Departments, the Chairman of the Joint Chiefs of Staff, the Combatant Commands, the Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD Field Activities, and all other organizational entities in the Department of Defense (hereafter collectively referred to as the “DoD Components”). Medical and associated enabling research supported by any DoD Component for prevention, mitigation, and treatment of blast injuries. | |
| language | English | |
| title | DODD 6025.21E(D) | num |
| title | MEDICAL RESEARCH FOR PREVENTION, MITIGATION, AND TREATMENT OF BLAST INJURIES | en |
| type | standard | |
| page | 10 | |
| status | Active | |
| tree | DODD - DoD Directives Service:;2006 | |
| contenttype | fulltext |

درباره ما